Literature DB >> 3456178

The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea.

P A Treseler, F Sanfilippo.   

Abstract

The well-characterized immunogenetic constitution of the rat has made it a valuable resource for the study of corneal transplantation. However, little is known about the expression of histocompatibility antigens in the rat cornea or about the populations of passenger leukocytes rat corneal grafts may contain. Thus the relevance of rat corneal transplantation to the human situation is unclear. We examined the expression of antigens of the histocompatibility complex (MHC) of the rat (RT1) and of antigens identifying rat leukocyte populations in corneas of selected rat strains using a sensitive immunoperoxidase technique. Class I MHC antigens were found in fairly uniform association with most cells of the rat corneal epithelium, endothelium, and stroma. In contrast, class II MHC antigens were not associated with most corneal parenchymal cells, but were clearly present on multiple isolated dendritic cells throughout the corneal stroma, especially near the limbus, and on very rare isolated cells in the limbal epithelium; these antigens were not detectable on the corneal endothelium. Cells expressing an antigen common to all rat leukocytes were present in a distribution similar to that of class II MHC antigen-bearing cells. There was no consistent expression of antigens associated with T lymphocytes, macrophages, neutrophils, or NK cells. It thus appears that the expression of MHC and leukocyte antigens by cells in the rat cornea is similar to that reported in the human, indicating that the rat may indeed provide a good model of human corneal transplantation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456178     DOI: 10.1097/00007890-198602000-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Cell subpopulations in failed human corneal grafts.

Authors:  L Kuffová; V Holán; L Lumsden; J V Forrester; M Filipec
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

Review 2.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Immunoregulatory properties of bone marrow-derived cells in the iris and ciliary body.

Authors:  J S Williamson; D Bradley; J W Streilein
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

Review 4.  Regional differences in immune regulation: the immunogenic privilege of corneal allografts.

Authors:  J Y Niederkorn; J S Peeler
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes.

Authors:  M A Galumbeck; F P Sanfilippo; P O Hagen; A V Seaber; J R Urbaniak
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

Review 6.  Corneal allograft rejection.

Authors:  D F Larkin
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

7.  Morphologic and immunophenotypic heterogeneity of corneal dendritic cells.

Authors:  L Catry; J Van den Oord; B Foets; L Missotten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  'Subthreshold stimulation' of allospecific delayed hypersensitivity by corneal allografts.

Authors:  J Y Niederkorn; E Mayhew
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

9.  Leflunomide therapy following penetrating keratoplasty in the rat.

Authors:  S E Coupland; S Klebe; A C Karow; L Krause; H Kruse; R R Bartlett; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

10.  Hydrolase participation in allograft rejection in rat penetrating keratoplasty.

Authors:  S Coupland; F Billson; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.